“The mortality rate from COVID-19 in countries that allow access to HCQ is only one-tenth the mortality rate in countries where there is interference with this medication, such as the United States. . . . In some areas of Central America, officials are even going door to door to distribute HCQ. . . . These countries have been successful in limiting the mortality from COVID-19 to only a fraction of what it is in wealthier countries.”
